Techstars Bangalore has announced the names of nine Indian startups for its 3rd cohort in India
AI and Us: Decision Making Should Not Be Outsourced to AI
AI literacy should become as important as digital literacy. An informed user is ultimately the first and most effective line of defence against blindly accepting what a machine tells us.
The Dangers of AI Bypassing the Human Mind: Can Indian Knowledge Systems provide a moral anchor for modern technology?
Rather than relying only on Western compliance checklists, AI development can be anchored in Atma-Bodha (self-awareness), training engineers to recognise how their algorithms alter human consciousness and social behaviour.
The Expanding Space Frontier: Can India Live Up to Its Challenges?
Biological systems behave very differently in orbit. Space research could lead to breakthroughs in cancer treatment, Alzheimer's therapies, protein crystallisation and even advanced prosthetics such as artificial retinas.
From Hashtags to Handcuffs: When Digital Democracy Becomes Digital Surveillance
India therefore needs a serious conversation on algorithmic accountability. If AI increasingly informs policing, citizens deserve clarity on its legal basis, safeguards against misuse, limits on data retention, independent oversight and effective judicial remedies.
More on AI, Tech and Innovation
Dr. Reddy’s Laboratories announce launch of Russia's Sputnik V vaccine in the Indian market
Dr. Reddy’s Laboratories Ltd on Friday announced that the first consignment of imported doses of the Russian Sputnik V vaccine that landed in India on May 1, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13
India's Bharat Biotech invites vaccine makers to manufacture Covaxin to scale up production
Hyderabad-based pharmaceutical company Bharat Biotech is willing to invite other companies which want to produce Covaxin to help meet the shortage in production, a top Indian government advisor said
Dr Reddy Labs enters into voluntary licensing agreement with Eli Lilly for Covid treatment in India
Dr Reddy’s Laboratories on Wednesday announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company (“Lilly”) for the manufacture and commercialization of the drug Baricitinib in India
India-made environment-friendly chocolates find growing market
A few start-ups in southern India are adopting sustainable and conscious practices to develop organic chocolate bars which have a niche but growing market in India
Nokia to make phones in Bangladesh
Finnish telecommunications giant Nokia is set to launch its first production unit in Bangladesh, officials said
Cathay Pacific undertakes delivery of emergency medical supplies to India
With India facing grave medical crisis, Cathay Pacific Cargo is flying vital relief shipments to India. Although passenger flights have been suspended between Hong Kong and India, in the past few weeks Cathay Pacific Cargo has been operating freighters and cargo-only passenger flights
Bangladesh to import rice from India
Bangladesh will import 50,000 tonnes of parboiled rice from India through the railways for the first time. The proposal was okayed by the cabinet committee on purchase at a meeting chaired by Finance Minister AHM Mustafa Kamal, Daily Star said
Landmark Israel, India and UAE trilateral renewable energy deal
The Embassy of Israel in India has announced the first-of-its-kind trilateral cooperation between Israel, India and the UAE
Roche India gets emergency use approval for its antibody cocktail that prevents severe infection
Pharma major Roche India has announced that it has received Emergency Use Approval (EUA) from Central Drugs Standards Control Organisation (CDSCO) for its antibody cocktail for treating COVID-19
India's domestic air traffic goes down by 29 pc in April
As a result of second wave of Covid-19 Indian carriers hit turbulence in April 2021 with a sharp decline in the number of flyers, said ICRA, the investment information and credit rating agency, today
Serum Institute of India to invest 240 million pounds in UK: PM Johnson
British PM Boris Johnson has announced that Serum Institute of India (SII), the manufacturers of the Oxford-Astrazeneca vaccine Covishield, will be investing 240 million pounds in the United Kingdom through the opening of a new sales office, media reports said
India government permits telecom service providers to begin 5G trial
The Indian government on Tuesday permitted telecom service providers to conduct trials for use and applications of 5G technology, an official release said
My comments misinterpreted, says SII CEO Adar Poonawalla
Serum Institute of India (SII) CEO Adar Poonawalla on Monday said his comments made last week to British newspaper The Times, in which he spoke about "aggressive" phone calls from influential people in India demanding an increased production of Covishield vaccine, have been "misinterpreted"
UAE money transfer firms waive remittance charges to India
Money transfer companies in the UAE are trying to contribute in their own way to fight the COVID-19 pandemic situation in India by waiving charges to funds being transferred to India’s PM Cares Fund and Kerala Chief Minister’s Distress Relief Fund to help the South Asian country
